Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Altman, Pablo" or (type any "bookEditor journalEditor issueEditor" and editor="Altman, Pa... Add to list Journal Article A1 Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER) Philippe Gevaert (UGent) , Claus Bachert (UGent) , Jorge Fernando Maspero, Mandy Cuevas, David Steele, Sandip Acharya and Pablo Altman (2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(5). p.1675-1682.e3 Add to list Journal Article A1 The pharmacology of the prostaglandin D-2 receptor 2 (DP2) receptor antagonist, fevipiprant Chris Brightling, Swarupa Kulkarni, Bart Lambrecht (UGent) , David Sandham, Markus Weiss and Pablo Altman (2021) PULMONARY PHARMACOLOGY & THERAPEUTICS. 68. Add to list Journal Article A1 The impact of the prostaglandin Dâ‚‚ receptor 2 and its downstream effects on the pathophysiology of asthma Christopher E Brightling, Guy Brusselle (UGent) and Pablo Altman (2020) ALLERGY. 75(4). p.761-768